Evidence map›Paper›PMID 40859748›Full record

ArticlePsychogeriatrics : the official journal of the Japanese Psychogeriatric Society2025

Late-Onset Oral Cenesthopathy With Dopaminergic Dysfunction: Therapeutic Response to Pramipexole in a Case With Suspected Prodromal Lewy Body Disease.

Hitomi Matsui, Takehiro Tamura, Masashi Kameyama, Yuki Omori, Genichi Sugihara, Takashi Takeuchi, Hidehiko Takahashi, Ko Furuta

Abstract readCase Reports
In one paragraph

Article in Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hitomi MatsuiTokyo Metropolitan Institute for Geriatrics and Gerontology, Itabashi, Japan.ORCID https://orcid.org/0009-0003-9268-2052
Takehiro TamuraDepartment of Psychiatry and Behavioral Sciences, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Japan.
Masashi KameyamaTokyo Metropolitan Institute for Geriatrics and Gerontology, Itabashi, Japan.
Yuki OmoriTokyo Metropolitan Institute for Geriatrics and Gerontology, Itabashi, Japan.
Genichi SugiharaDepartment of Psychiatry and Behavioral Sciences, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Japan.
Takashi TakeuchiDepartment of Psychiatry and Behavioral Sciences, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Japan.
Hidehiko TakahashiDepartment of Psychiatry and Behavioral Sciences, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Japan.
Ko FurutaTokyo Metropolitan Institute for Geriatrics and Gerontology, Itabashi, Japan.

Funding

Japan Society for the Promotion of Science KAKENHI JP (24K18736)
6 · The paper itself

Abstract

An 85-year-old woman with late-onset depression subsequently developed persistent oral cenesthopathy. As antidepressant augmentation, low-dose aripiprazole improved both mood and oral symptoms, but oversedation and parkinsonism necessitated tapering and discontinuation. After discontinuation, oral cenesthopathy recurred without clear depressive worsening. Dopamine transporter single-photon emission computed tomography showed reduced bilateral striatal uptake and

Indexed as

Dopamine AgonistsLewy Body DiseasePramipexoleAged, 80 and overBenzothiazolesFemaleHumansProdromal SymptomsTomography, Emission-Computed, Single-PhotonTreatment OutcomeBenzothiazolesDopamine AgonistsPramipexoledopaminergic dysfunctionlate‐onset depressionoral cenesthopathypramipexoleprodromal Lewy body disease

Identifiers

PMID40859748
PMCPMC12381603

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.